Brian Christopher Bales

USPTO Granted Patents = 19 (Patent Applications = 9)

EPO Patents = 13 (Patent Applications = 12)

Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 120(Granted Patents)

Company Filing History:

16 out of 51,873

General Electric Company

Global Life Sciences Solutions Operations UK Ltd

patents

Years Active: 2007-2024

Loading Chart...

19 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11884686 - Chelate compounds (2024-01-30),

2. 11754563 - Porous membranes with a polymer grafting, methods and uses thereof (2023-09-12),

3. 11714084 - Method and associated device for rapid detection of target biomolecules with enhanced sensitivity (2023-08-01),

4. 11110186 - Anionic chelate compounds (2021-09-07),

5. 10837962 - Method and associated device for rapid detection of target biomolecules with enhanced sensitivity (2020-11-17),

6. 10730897 - Manganese chelate compounds (2020-08-04),

7. 9827335 - Treating water insoluble nanoparticles with hydrophilic alpha-hydroxyphosphonic acid conjugates, the so modified nanoparticles and their use as contrast agents (2017-11-28),

8. 9534214 - Substrates and associated methods for elution of nucleic acids (2017-01-03),

9. 9474810 - Superparamagnetic nanoparticles with PEG substituted α-hydroxy phosphonate shells (2016-10-25),

10. 9399075 - Nanoparticle contrast agents for diagnostic imaging (2016-07-26),

11. 9251937 - Heat stable nanoparticle preparations and associated methods thereof (2016-02-02),

12. 9205155 - Treating water insoluble nanoparticles with hydrophilic alpha-hydroxyphosphonic acid conjugates, the so modified nanoparticles and their use as contrast agents (2015-12-08),

13. 9040679 - Methods and compositions for extraction and storage of nucleic acids (2015-05-26),

14. 9040675 - Formulations for nucleic acid stabilization on solid substrates (2015-05-26),

15. 8895068 - Nanoparticle composition and associated methods thereof (2014-11-25),

Title: Innovations and Impact of Brian Christopher Bales

Introduction

Brian Christopher Bales, based in Niskayuna, NY, is a prolific inventor with an impressive portfolio of 19 patents. His contributions to the fields of medical imaging and biochemistry reflect a commitment to advancing technology and improving healthcare outcomes.

Latest Patents

Among his latest innovations, Bales has developed chelate compounds that serve as contrast agents in magnetic resonance imaging (MRI). These manganese (II) complexes possess advantageous properties compared to existing compounds, enhancing the quality of medical imaging. Additionally, Bales has created porous membranes with polymer grafting, which include a modified porous membrane designed for analyte detection from biological samples through immunoassays. This innovative device features a sample application zone for biological samples and a detection zone equipped with immobilized biomolecules, facilitating accurate target analyte detection.

Career Highlights

Bales has garnered substantial experience during his career, having worked for esteemed companies such as General Electric Company and GE Healthcare. His role in these organizations allowed him to leverage his inventive spirit, contributing to groundbreaking advancements in healthcare technology.

Collaborations

Throughout his career, Bales collaborated with notable professionals such as Bruce Allan Hay and Michael Todd Luttrell. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment to drive innovation.

Conclusion

Brian Christopher Bales stands out as a significant figure in the realm of inventions, particularly in healthcare technology. His ongoing contributions are poised to make a lasting impact on the industry, underscoring the importance of innovation in improving diagnostic methodologies.

This text is generated by artificial intelligence and may not be accurate.